Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Puertas

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Research|September 14, 2014
Modeling lung cancer evolution and preclinical response by orthotopic mouse allograftsChiara Ambrogio, Francisco J Carmona, August Vidal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processingSonia Melo, Alberto Villanueva, Catia Moutinho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing AgentJosep M Piulats, August Vidal, Francisco J García-Rodríguez, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Research|September 14, 2014
Modeling lung cancer evolution and preclinical response by orthotopic mouse allograftsChiara Ambrogio, Francisco J Carmona, August Vidal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processingSonia Melo, Alberto Villanueva, Catia Moutinho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing AgentJosep M Piulats, August Vidal, Francisco J García-Rodríguez, et al.
Pageof 2